Parameters Indicating Development of Influenza-Associated Acute Necrotizing Encephalopathy: Experiences from a Single Center.
Acute Disease
Alanine Transaminase
/ blood
Aquaporins
/ blood
Aspartate Aminotransferases
/ blood
Biomarkers
/ blood
Brain Diseases
/ blood
Cerebrospinal Fluid
/ metabolism
Child, Preschool
Female
Glucocorticoids
/ blood
Humans
Immunoglobulins, Intravenous
/ blood
Influenza, Human
/ blood
L-Lactate Dehydrogenase
/ blood
Male
Malondialdehyde
/ blood
Neuroimaging
/ methods
Seizures
/ blood
Journal
Medical science monitor : international medical journal of experimental and clinical research
ISSN: 1643-3750
Titre abrégé: Med Sci Monit
Pays: United States
ID NLM: 9609063
Informations de publication
Date de publication:
02 May 2021
02 May 2021
Historique:
entrez:
2
5
2021
pubmed:
3
5
2021
medline:
2
6
2021
Statut:
epublish
Résumé
BACKGROUND Influenza-associated acute necrotizing encephalopathy (IANE) can be lethal and disabling and have a sudden onset and deteriorate rapidly but lacks early diagnostic indicators. We aimed to examine the early clinical diagnostic indicators in children with IANE. MATERIAL AND METHODS Acute influenza patients were grouped according to their clinical manifestations: flu alone (FA), flu with febrile seizure (FS), influenza-associated encephalopathy (IAE), and IANE. The clinical features, biomarkers, neuroelectrophysiological results, and neuroimaging examination results were compared. RESULTS A total of 31 patients were included (FA (n=4), FS (n=8), IAE (n=14), and IANE (n=5)). The IANE group, whose mean age was 3.7 years, was more likely to show rapid-onset seizure, acute disturbance of consciousness (ADOC), Babinski's sign, and death/sequela. More patients in the IANE group required tracheal intubation mechanical ventilation and received intravenous immunoglobulins (IVIG) and glucocorticoids. The alanine aminotransferase (ALT), aspartate transaminase (AST), and lactate dehydrogenase (LDH) levels in the IANE group were significantly higher than in the FS and IAE groups. The aquaporin-4 (AQP-4) antibody and malondialdehyde (MDA) levels in the serum and cerebrospinal fluid (CSF) were notably higher in IANE patients in the acute stage compared with FS and IAE patients. All patients in the IANE group had positive neuroimaging findings. CONCLUSIONS Early clinical warning factors for IANE include rapid-onset seizures in patients under 4 years of age, ADOC, and pathological signs. Increased AQP-4 antibodies and MDA levels in CSF might contribute to early diagnosis. Early magnetic resonance venography (MRV) and susceptibility-weighted imaging (SWI) sequences, or thrombelastography to identify deep vein thrombosis, might indicate clinical deterioration.
Identifiants
pubmed: 33934098
pii: 930688
doi: 10.12659/MSM.930688
pmc: PMC8101270
doi:
Substances chimiques
Aquaporins
0
Biomarkers
0
Glucocorticoids
0
Immunoglobulins, Intravenous
0
Malondialdehyde
4Y8F71G49Q
L-Lactate Dehydrogenase
EC 1.1.1.27
Aspartate Aminotransferases
EC 2.6.1.1
Alanine Transaminase
EC 2.6.1.2
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
e930688Références
Toxicon. 2000 Oct;38(10):1389-402
pubmed: 10758274
Neurology. 2005 Jul 26;65(2):192-6
pubmed: 16043785
Mediators Inflamm. 2015;2015:792578
pubmed: 25873770
Brain Pathol. 2010 Jan;20(1):261-4
pubmed: 20438486
Am Heart J. 1999 Jun;137(6):1145-52
pubmed: 10347344
J Infect Chemother. 2017 Feb;23(2):80-84
pubmed: 27887787
Clin Neuroradiol. 2020 Jun;30(2):243-249
pubmed: 30610262
Virus Res. 2004 Jul;103(1-2):75-8
pubmed: 15163492
Curr Opin Pediatr. 2017 Jun;29(3):297-302
pubmed: 28346272
Brain Dev. 2019 Jan;41(1):85-95
pubmed: 30057207
J Neuroinflammation. 2013 Oct 18;10:128
pubmed: 24139226
Pediatrics. 2013 Nov;132(5):796-804
pubmed: 24167165
Neurochem Res. 2015 Dec;40(12):2615-27
pubmed: 25630715
Biomarkers. 2008 Mar;13(2):184-200
pubmed: 18270870
Clin Hemorheol Microcirc. 2010;45(2-4):123-30
pubmed: 20675892
Br J Haematol. 2018 Sep;182(6):789-806
pubmed: 30073664
Pediatr Neurol. 2006 Apr;34(4):315-8
pubmed: 16638510
Immunology. 1987 Sep;62(1):153-5
pubmed: 3653925
J Appl Toxicol. 1996 Jan-Feb;16(1):35-41
pubmed: 8821673
Nihon Rinsho. 2011 Mar;69(3):399-408
pubmed: 21400830
Semin Pediatr Infect Dis. 2002 Apr;13(2):79-84
pubmed: 12122956
No Shinkei Geka. 1976 Aug;4(8):753-62
pubmed: 986569
J Infect Dis. 2012 Sep 15;206(6):838-46
pubmed: 22829641
J Med Case Rep. 2017 Sep 26;11(1):281
pubmed: 28950885
J Korean Med Sci. 2019 May 20;34(19):e143
pubmed: 31099193
Neuroradiology. 2003 Sep;45(9):661-2; author reply 663
pubmed: 12904926
Pediatr Int. 2000 Apr;42(2):204-14
pubmed: 10804743
Pediatr Neurol. 2015 Jul;53(1):93-4
pubmed: 25937389
Acta Neuropathol. 2003 Mar;105(3):233-9
pubmed: 12557009
J Neurosci. 2015 Sep 30;35(39):13525-37
pubmed: 26424896
AJNR Am J Neuroradiol. 2004 May;25(5):798-802
pubmed: 15140723
AJNR Am J Neuroradiol. 2004 May;25(5):792-7
pubmed: 15140722
J Neurol Neurosurg Psychiatry. 1995 May;58(5):555-61
pubmed: 7745402
Ann Neurol. 2010 Jul;68(1):111-4
pubmed: 20582943
J Pediatric Infect Dis Soc. 2018 Aug 17;7(3):e172-e177
pubmed: 29741717
Toxicol Lett. 2012 Oct 2;214(1):33-45
pubmed: 22909951
Curr Opin Pediatr. 2010 Dec;22(6):751-7
pubmed: 21610332
Anaesthesist. 2015 Oct;64(10):778-94
pubmed: 26136120
AJNR Am J Neuroradiol. 2010 Mar;31(3):396-400
pubmed: 20231352
Brain Dev. 2015 Mar;37(3):322-7
pubmed: 24931733
Nihon Rinsho. 2010 Sep;68(9):1661-5
pubmed: 20845744
Ann Clin Lab Sci. 2014 Summer;44(3):241-8
pubmed: 25117093
Acta Physiol (Oxf). 2014 Apr;210(4):790-8
pubmed: 24629161
J Child Neurol. 2014 Sep;29(9):NP49-53
pubmed: 24072018
Microbiol Immunol. 2009 May;53(5):277-80
pubmed: 19457168
Brain Dev. 2018 Oct;40(9):799-806
pubmed: 29891404
MMWR Morb Mortal Wkly Rep. 2010 Aug 27;59(33):1057-62
pubmed: 20798667
Neurocrit Care. 2011 Aug;15(1):156-60
pubmed: 21465323
Clin Med Insights Case Rep. 2016 Nov 01;9:99-102
pubmed: 27812294
Eur J Anaesthesiol. 2013 Jun;30(6):270-382
pubmed: 23656742
Farm Hosp. 2013 May-Jun;37(3):209-35
pubmed: 23789799
Lancet Neurol. 2007 Feb;6(2):162-70
pubmed: 17239803
Handb Clin Neurol. 2016;133:377-403
pubmed: 27112688
Neuroradiology. 2002 Jun;44(6):489-93
pubmed: 12070722
Pediatr Neurol. 2011 Dec;45(6):400-2
pubmed: 22115004
Neurochem Int. 2009 Jul-Aug;55(1-3):129-35
pubmed: 19428817
J Clin Virol. 2003 Dec;28(3):225-32
pubmed: 14522059
Neuropathol Appl Neurobiol. 2015 Jun;41(4):e80-94
pubmed: 25201550